Literature DB >> 15247186

Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes.

D Basso1, C Millino, E Greco, C Romualdi, P Fogar, A Valerio, M Bellin, C-F Zambon, F Navaglia, N Dussini, A Avogaro, S Pedrazzoli, G Lanfranchi, M Plebani.   

Abstract

BACKGROUND AND AIMS: We verified whether conditioned media (CM) from pancreatic cancer cell lines (MIAPaCa2, CAPAN-1, PANC-1, BxPC3) alter glucose metabolism and gene expression profiles (microarray experiment with a platform of 5000 skeletal muscle cDNA) in mice myoblasts.
METHODS: Myoblasts were incubated with control or pancreatic cancer CM for 24 and 48 hours.
RESULTS: Lactate significantly increased in CM compared with non-conditioned myoblasts. No variations in expression levels of the main genes involved in glycolysis were found in CM myoblasts. Propionyl coenzyme A carboxylase and isocitrate dehydrogenase 3 beta genes, which encode enzymes of the tricarboxylic acid cycle, were overexpressed, while IGFIIR and VAMP5 genes were underexpressed in CM myoblasts. PAFAH1B1 and BCL-2 genes (intracellular signal transduction) and the serine protease cathepsin G (proteolysis), were overexpressed in CM myoblasts. Tyrosine accumulation in CM myoblasts suggested that proteolysis overcomes protein synthesis. Sorcin, actin alpha, troponin T1, and filamin A were underexpressed in CM myoblasts.
CONCLUSIONS: Our findings demonstrate that pancreatic cancer cell conditioned media enhanced lactate production and induced proteolysis, possibly by altering expression levels of a large number of genes, not only those involved in protein biosynthesis and degradation or glucose metabolism, but also those involved in the tricarboxylic acid cycle and in vesicle traffic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247186      PMCID: PMC1774152          DOI: 10.1136/gut.2003.024471

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  39 in total

1.  Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: a low molecular weight factor possibly involved.

Authors:  A Valerio; D Basso; L Brigato; G Ceolotto; G Baldo; A Tiengo; M Plebani
Journal:  Biochem Biophys Res Commun       Date:  1999-04-13       Impact factor: 3.575

2.  Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer.

Authors:  D R Brown; D E Berkowitz; M J Breslow
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

Review 3.  Antisense therapy for cancer--the time of truth.

Authors:  Burkhard Jansen; Uwe Zangemeister-Wittke
Journal:  Lancet Oncol       Date:  2002-11       Impact factor: 41.316

4.  Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study.

Authors:  A Avogaro; G Toffolo; A Valerio; C Cobelli
Journal:  Diabetes       Date:  1996-10       Impact factor: 9.461

Review 5.  Structures, functions and molecular evolution of the penta-EF-hand Ca2+-binding proteins.

Authors:  Masatoshi Maki; Yasuyuki Kitaura; Hirokazu Satoh; Susumu Ohkouchi; Hideki Shibata
Journal:  Biochim Biophys Acta       Date:  2002-11-04

6.  Diabetes mellitus in pancreatic cancer follow-up.

Authors:  P Fogar; C Pasquali; D Basso; C Sperti; M P Panozzo; G Tessari; F D'Angeli; G Del Favero; M Plebani
Journal:  Anticancer Res       Date:  1994 Nov-Dec       Impact factor: 2.480

Review 7.  Insulin-like growth factors and cancer.

Authors:  Gregor Fürstenberger; Hans-Jörg Senn
Journal:  Lancet Oncol       Date:  2002-05       Impact factor: 41.316

8.  Gene expression profiling in dysferlinopathies using a dedicated muscle microarray.

Authors:  Stefano Campanaro; Chiara Romualdi; Marina Fanin; Barbara Celegato; Beniamina Pacchioni; Silvia Trevisan; Paolo Laveder; Cristiano De Pittà; Elena Pegoraro; Yukiko K Hayashi; Giorgio Valle; Corrado Angelini; Gerolamo Lanfranchi
Journal:  Hum Mol Genet       Date:  2002-12-15       Impact factor: 6.150

9.  A case-control study of diabetes mellitus and cancer risk.

Authors:  C La Vecchia; E Negri; S Franceschi; B D'Avanzo; P Boyle
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

10.  Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer.

Authors:  D T Silverman; M Schiffman; J Everhart; A Goldstein; K D Lillemoe; G M Swanson; A G Schwartz; L M Brown; R S Greenberg; J B Schoenberg; L M Pottern; R N Hoover; J F Fraumeni
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

View more
  18 in total

1.  Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer.

Authors:  Katherine Y Fan; Avani S Dholakia; Aaron T Wild; Zheng Su; Amy Hacker-Prietz; Rachit Kumar; Mary Hodgin; Charles C Hsu; Dung T Le; Ana De Jesus-Acosta; Luis A Diaz; Daniel A Laheru; Ralph H Hruban; Elliot K Fishman; Todd D Brown; Timothy M Pawlik; Christopher L Wolfgang; Phuoc T Tran; Joseph M Herman
Journal:  J Natl Compr Canc Netw       Date:  2014-01       Impact factor: 11.908

Review 2.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Authors:  Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

3.  Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.

Authors:  Wenchao Gao; Yu Zhou; Qingyan Li; Quanbo Zhou; Langping Tan; Yadong Song; Xiaohui Zhao; Min Yu; Shangyou Zheng; Huilin Ye; Bing Zeng; Qing Lin; Jiajia Zhou; Yimin Liu; Huaiqiu Huang; Hui Zhang; Xuchu Hu; Zhihua Li; Xianhua Dai; Rufu Chen
Journal:  Diabetologia       Date:  2015-01-31       Impact factor: 10.122

Review 4.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

Review 5.  The early diagnosis of pancreatic cancer and diabetes: what's the relationship?

Authors:  Changsong Zhang; Guangshun Yang; Yang Ling; Guihua Chen; Tianbao Zhou
Journal:  J Gastrointest Oncol       Date:  2014-12

6.  Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.

Authors:  Gaurav Aggarwal; Vijaya Ramachandran; Naureen Javeed; Thiruvengadam Arumugam; Shamit Dutta; George G Klee; Eric W Klee; Thomas C Smyrk; William Bamlet; Jing Jing Han; Natalia B Rumie Vittar; Mariza de Andrade; Debabrata Mukhopadhyay; Gloria M Petersen; Martin E Fernandez-Zapico; Craig D Logsdon; Suresh T Chari
Journal:  Gastroenterology       Date:  2012-09-06       Impact factor: 22.682

7.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

Review 8.  Glucose metabolic phenotype of pancreatic cancer.

Authors:  Anthony K C Chan; Jason I E Bruce; Ajith K Siriwardena
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 9.  New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer.

Authors:  Rahul Pannala; Ananda Basu; Gloria M Petersen; Suresh T Chari
Journal:  Lancet Oncol       Date:  2009-01       Impact factor: 41.316

10.  Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus.

Authors:  Rahul Pannala; Jeffery B Leirness; William R Bamlet; Ananda Basu; Gloria M Petersen; Suresh T Chari
Journal:  Gastroenterology       Date:  2008-01-18       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.